Aarhus University Seal / Aarhus Universitets segl

Association between eczema and major cardiovascular outcomes in population-based studies: a systematic review protocol

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  • Anna Ascott, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, United Kingdom.
  • ,
  • Ashley M Yu, Children's Hospital of Eastern Ontario Research Institute, 401 Smyth Road, Ottawa, Ontario, K1H 8L1, Canada; Department of Pediatrics, Faculty of Medicine, University of Ottawa, 401 Smyth Road Ottawa, Ontario, K1H 8L1, Canada. Electronic address: ktoupin@cheo.on.ca.
  • ,
  • Morten Schmidt
  • Katrina Abuabara
  • ,
  • Liam Smeeth, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, United Kingdom.
  • ,
  • Sinéad M Langan, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, United Kingdom.

INTRODUCTION: Chronic inflammatory diseases such as eczema (also known as atopic dermatitis) have been inconsistently linked to cardiovascular disease and stroke in both mechanistic and epidemiological studies. There is a need to review the existing epidemiological data examining the association between eczema and major cardiovascular outcomes, including angina, myocardial infarction, coronary revascularisation, heart failure, cardiac arrhythmias, stroke and cardiovascular death, in order to improve our understanding of the comorbidities of eczema.

METHODS AND ANALYSIS: We will systematically review population-based studies, including cohort, case-control and cross-sectional studies, reporting on the association between eczema and cardiovascular outcomes. We will search Medline, Embase and Global Health, from their date of inception to April 2017, using a comprehensive search strategy formulated with the help of a librarian. Two reviewers will independently screen titles and abstracts in duplicate, followed by independent data extraction and quality assessment. We will group studies by the cardiovascular outcome under study and synthesise them narratively. If sufficient numbers of homogeneous studies are returned, we will perform meta-analyses to obtain pooled effect estimates. Preferred Reporting Items for Systematic Review and Meta-Analysis will be used to inform the reporting of this study.

TRIAL REGISTRATION NUMBER: CRD42017060359.

Original languageEnglish
JournalBMJ Open
Volume7
Issue9
Pages (from-to)e017979
ISSN2044-6055
DOIs
Publication statusPublished - 29 Sep 2017

    Research areas

  • Journal Article

See relations at Aarhus University Citationformats

ID: 119198009